Sertralin Bluefish

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Sertralin Bluefish

What is Sertralin Bluefish? A Foundational Overview

Property Description
Active ingredient Sertraline hydrochloride
Form Oral film-coated tablet
Pharmacological class Selective Serotonin Re-uptake Inhibitor (SSRI)
Origin Synthetic psychoactive compound
Regulatory Status Prescription-only medicine (Rx)

Defining Sertralin Bluefish: A Selective Serotonin Re-uptake Inhibitor (SSRI)

Sertralin Bluefish is a synthetic, prescription-only medicine containing the active substance Sertraline hydrochloride. This compound belongs to the pharmacological class of Selective Serotonin Re-uptake Inhibitors (SSRIs), which are established therapeutic agents. The medication is designed for oral administration and is typically presented as a film-coated tablet. Sertralin Bluefish is a generic presentation supplied by Bluefish Pharmaceuticals, maintaining the same efficacy and safety standards as the original brand formulation, but is identified by its specific manufacturer and trade name.

The Core Principle: How Sertraline Affects Brain Chemistry

Sertraline's core principle is linked to modulating the activity of the brain’s primary mood-regulating chemical, serotonin. As an SSRI, its mechanism involves selectively blocking the reabsorption process, known as neuronal re-uptake, of serotonin into the nerve endings. This action leads to a net increase in the effective concentration of serotonin in the central nervous system. This increased availability helps to gradually stabilize the chemical signaling pathways related to emotional processing.

General Purpose and Therapeutic Context

The general purpose of this medicine is to promote the chemical balance necessary for stabilizing mood and regulating emotional response. Sertraline is broadly recognized as an antidepressant agent, utilized for its capacity to enhance serotonergic activity, which can help alleviate symptoms of excessive worry, persistent sadness, and general emotional distress. The overall goal is to restore equilibrium within the central nervous system to support improved functional capacity and well-being.

Regulatory References

  1. NIH StatPearls Sertraline Mechanism of Action
Advertisements

What side effects are possible with Sertralin Bluefish?

Possible Side Effects and Safety Information

The official safety profile of Sertraline (Sertralin Bluefish) is structured by regulatory bodies, such as the FDA and EMA, to classify documented adverse reactions and safety constraints. All listed effects are derived strictly from authoritative government labeling.

Classification Examples of Officially Documented Adverse Reactions
Very Common (ge 1/10) Gastrointestinal effects like nausea and diarrhoea; insomnia, headache, somnolence (drowsiness), and fatigue (General Disorders).
Common (ge 1/100 to < 1/10) Decreased appetite, constipation, tremor, dizziness, anxiety, and sexual dysfunction (e.g., ejaculation failure, decreased libido) across relevant system-organ classes.

Serious Adverse Reactions (Label-Documented):

The label highlights specific, potentially serious events, including Serotonin Syndrome (a serious reaction involving changes in mental status, muscle rigidity, and fever), increased risk of bleeding (e.g., dermal or gastrointestinal haemorrhage), and Hyponatraemia (low sodium levels), particularly in older adults. Seizures have also been reported in regulatory documentation.

Population-Specific Safety Notes:

Official labeling contains specific constraints for certain groups. The pediatric population (children and adolescents) has a documented warning regarding an increased risk of suicidal thoughts and behavior. For patients with hepatic impairment (liver disease), caution is advised due to reduced drug clearance, which may necessitate a lower or less frequent dose. Use in the third trimester of pregnancy is associated with risks of Persistent Pulmonary Hypertension of the Newborn (PPHN) and neonatal withdrawal symptoms.

Exposure-Related Patterns and Constraints:

Certain effects, such as anxiety and insomnia, may be more frequent at the initiation of treatment or following a dose increase. Conversely, regulatory documents note that a discontinuation syndrome (e.g., dizziness, agitation, sensory disturbances) is common upon stopping the medicine. The medicine is formally contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs).

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Sertraline, including Sertralin Bluefish, can occur when taken alone or, more commonly, in combination with other substances and/or alcohol. Any suspected overdose requires immediate, aggressive medical attention.

Documented Overdose Manifestations

Reported signs and symptoms of overdose, based on regulatory labeling, frequently include central nervous system (CNS) effects and gastrointestinal distress. These manifestations may include:

  • Somnolence (drowsiness)
  • Tachycardia (rapid heart rate)
  • Nausea and vomiting
  • Tremor, agitation, and dizziness
  • Confusion, sweating, and fever

Severe and Life-Threatening Outcomes

Serious complications have been reported following overdose, indicating the need for immediate emergency intervention. These include seizures, coma, and Serotonin Syndrome, which can present as rapid changes in mental status, vital signs, and neuromuscular activity. Cardiac risks, such as QTc prolongation and arrhythmias, have also been documented.

Emergency Actions and Management

Call emergency services immediately if a suspected overdose has led to collapse, seizure, trouble breathing, or unresponsiveness. The official guidance states there is no specific antidote for Sertraline overdose. Management is symptomatic and supportive. Activated charcoal may be utilized as part of medical management. Due to potential cardiac risks, monitoring of vital signs and an electrocardiogram (ECG) are typically required in a healthcare setting.

Advertisements

Therapeutic Uses of Sertralin Bluefish

What Sertralin Bluefish Treats: Main Uses and Benefits

Sertralin Bluefish is commonly used to help manage symptoms associated with several major psychiatric disorders, providing therapeutic support across critical domains. It is relevant in clinical settings marked by heightened distress and when symptoms noticeably interfere with daily stability, and may contribute to improved comfort during periods of heightened symptoms.

The medication is applied across domains where additional symptomatic support is needed, primarily addressing Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), Social Anxiety Disorder (SAD), and Premenstrual Dysphoric Disorder (PMDD). The overarching goal of management is to support the moderation of emotional responses across these conditions.

Quick Fact: Relief for Intrusive Thoughts

Quick Fact: Relief for Intrusive Thoughts Sertraline is commonly used to help manage the frequency and severity of recurrent obsessive thoughts and the associated compulsive ritualistic behaviors that characterize OCD in both adults and pediatric patient groups.

Regulatory References

  1. DailyMed official labeling overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Sertralin Bluefish?

The eligibility to use Sertralin Bluefish is strictly defined by official regulatory documentation, primarily based on age, concurrent medical treatments, and certain health conditions.


Absolute Contraindications

Sertralin Bluefish must not be used if any of the following apply:

  • You have a known hypersensitivity or allergy to sertraline.
  • You are currently taking, or have stopped taking within the last 14 days, a Monoamine Oxidase Inhibitor (MAOI), including linezolid.
  • You are concurrently taking the medicine pimozide.

Age and Condition Restrictions

  • Adults are eligible for all approved indications. The medicine is formally approved for pediatric patients (ages 6–17) only for Obsessive-Compulsive Disorder (OCD); use for other conditions in this age group is generally not established.
  • Caution is required in older adults, patients with a history of mania or seizures, or those with hepatic (liver) impairment. Use is generally not recommended for severe hepatic impairment.
  • Use during the third trimester of pregnancy may carry a risk of persistent pulmonary hypertension in the newborn, and caution is advised during breastfeeding.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sertraline's official interaction profile is defined by both pharmacokinetic and pharmacodynamic mechanisms as documented in regulatory sources.

Mandatory Restrictions and Timing Rules

Co-administration is formally contraindicated with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and intravenous Methylene Blue, due to the high risk of Serotonin Syndrome. A mandatory 14-day washout period must elapse after stopping an irreversible MAOI before Sertraline can be initiated, and a 7-day period is required before switching from Sertraline to an irreversible MAOI. The combination with the antipsychotic Pimozide is also prohibited, as regulatory data show an increase in Pimozide plasma levels.

Exposure, Metabolism, and Bleeding Risk

Sertraline is officially documented as a mild inhibitor of the CYP2D6 enzyme, which may increase the exposure of co-administered medicines metabolized by this pathway. Co-administration with Cimetidine is noted to cause a significant increase in Sertraline plasma concentration (decreased clearance). Pharmacodynamic interactions increase the regulatory-documented risk of bleeding when used with anticoagulants like Warfarin or antiplatelet drugs such as NSAIDs, due to documented effects on platelet function.

Other Documented Interactions

Concomitant use with other serotonergic agents, such as Triptans, certain Opioids, or the herbal product St. John's Wort, increases the official risk of enhanced serotonergic effects. Administration of the tablet formulation with food is documented to increase Sertraline absorption by approximately 25%. Regulatory caution is advised for patients with hepatic impairment, as reduced Sertraline clearance in this population may increase the severity of documented interactions.

Advertisements

Mechanism of Action

Sertralin Bluefish operates primarily as a selective serotonin reuptake inhibitor (SSRI). Its principal biological target is the serotonin transporter (SERT), a presynaptic membrane protein responsible for clearing serotonin (5-HT) from the synaptic cleft via reuptake into the presynaptic neuron.

Sertraline acts as a non-competitive inhibitor of SERT, binding to an allosteric site on the transporter and inducing a conformational change that blocks the 5-HT binding site and impedes the active transport of 5-HT. This molecular interaction results in a reduced rate of 5-HT reuptake.

The intracellular consequence is an acute and localized increase in the concentration of extracellular 5-HT within the synaptic cleft. This increased concentration enhances the stimulation of postsynaptic 5-HT receptors in the targeted central nervous system (CNS) tissue.

Downstream system-level physiological consequences include a modulation of serotonergic neurotransmission and subsequent alterations in neuronal activity in key brain circuits, specifically the raphe nuclei projections to the forebrain.

Advertisements

Dosage and Administration Information

How to Use Sertraline (Sertralin Bluefish)

This section outlines the standard administration and dosing instructions for sertraline.


Administration and Dosing

Guideline Instruction
Route of Administration Sertraline is for oral administration only.
Standard Adult Dose The typical starting dose for most indications is 50 mg once daily. The starting dose for Panic Disorder, Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder (SAD) is 25 mg once daily for the first week, followed by an increase to 50 mg daily.
Maximum Daily Dose The maximum recommended daily dose is 200 mg.
Frequency and Schedule The medication should be taken once daily. Doses may be adjusted, but at intervals of at least one week and in increments no greater than 50 mg.

Administration Requirements

Guideline Instruction
Intake Conditions (Tablets) Sertraline tablets may be administered with or without food.
Concentrate Preparation The oral concentrate must be diluted immediately before use in four ounces (1/2 cup) of water, ginger ale, lemon/lime soda, lemonade, or orange juice only. It must be taken with food.
Missed Dose If a dose is missed, skip the missed dose and take the next scheduled dose at the regular time. Do not double the dose.
Discontinuation Abrupt cessation should be avoided. The dose must be gradually reduced over a period of time under medical supervision.

Population-Specific Dosing

Dosage adjustments are specifically noted for patients with hepatic impairment, where lower doses are typically advised. Initial doses for children and adolescents (ages 6–17) being treated for Obsessive-Compulsive Disorder (OCD) vary by age group, starting at 25 mg or 50 mg once daily.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sertralin Bluefish

This section provides a factual overview of the types of research studies that have examined Sertralin Bluefish. It describes what was studied, what has been reported, and what aspects of the research remain to be fully understood.


Evidence Overview for Major Depressive Disorder (MDD)

Research has explored Sertralin Bluefish in contexts associated with Major Depressive Disorder. The evidence base includes Randomized Controlled Trials (RCTs) that examine changes in depressive symptom severity and anxiety symptom reduction, typically over 6 to 12 weeks. Findings describe patterns observed in the measured symptoms of adults, children, and adolescents.

Data show patterns related to symptom change in populations with co-occurring anxiety, where research reports that changes in anxiety outcomes were observed earlier than other measured outcomes. Interpretation of findings is affected by the high rates of placebo response observed in the research for this condition. Furthermore, it is not yet clear whether reported findings related to anxiety reduction differ from outcomes for symptoms like low mood and loss of pleasure.


Evidence Overview for Obsessive-Compulsive Disorder (OCD) and Panic Disorder (PD)

Obsessive-Compulsive Disorder (OCD)

Research was evaluated in populations of adults, children, and adolescents with OCD. Studies include RCTs and long-term continuation study designs, monitoring measured symptom changes and relapse patterns over intervals up to 80 weeks. Long-term outcomes have not been extensively studied outside of these defined trial periods.

Panic Disorder (PD)

Research for Panic Disorder consists of Double-blind Multicenter Trials monitored over a 10-week assessment period. Researchers measured the frequency of panic attacks. The research was focused on this acute phase, and long-term outcomes have not been extensively studied regarding the maintenance of symptom patterns after this short trial period.


Evidence Overview for Trauma and Anxiety-Related Conditions (PTSD and SAD)

  • Post-Traumatic Stress Disorder (PTSD): Research monitored overall symptom severity over a 12-week acute phase. Findings were mixed across different patient subgroups. Research describes variability in outcomes for specific populations, such as veterans with combat-related PTSD. Symptom change was observed to continue beyond the 12-week acute trial duration.

  • Social Anxiety Disorder (SAD): The evidence is derived from Double-blind Placebo-controlled Studies examining social anxiety symptoms over 10 to 20 weeks. Long-term outcomes have not been extensively studied, and results apply only to the populations studied, as many trials excluded patients with other major psychiatric conditions.


Evidence in Specific Populations and Gaps

Sertralin Bluefish was evaluated in cohorts of children and adolescents for MDD and OCD, and in patients defined by high symptom severity. However, data for certain groups are still emerging. For instance, subgroup findings appear to be limited for specific populations like veterans with combat-related PTSD, and data for long-term outcomes remain insufficient in many of these special groups.

Research gaps are still being explored regarding comparative evidence and the influence of the high placebo response rates observed in trials for conditions like MDD and Premenstrual Dysphoric Disorder (PMDD).

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Sertralin Bluefish (FAQ)

Q: Is Sertralin Bluefish the same as Zoloft?

Sertralin Bluefish is a generic version of the medicine containing the active ingredient sertraline hydrochloride. Zoloft is the original brand name for this same active ingredient. Official regulatory information confirms that generic medicines like Sertralin Bluefish are held to the same standards of quality, safety, and effectiveness as the original brand.


Q: Is it normal to feel worse when first starting Sertralin Bluefish?

Official product information notes that adverse reactions such as anxiety and insomnia (difficulty sleeping) may be more frequent when treatment is initiated or when the dose is increased. This is a pattern observed in clinical settings, and these initial effects may resolve or diminish as treatment continues.


Q: Are there withdrawal symptoms when stopping Sertralin Bluefish?

Regulatory documents state that a discontinuation syndrome is common upon stopping the medicine. Abrupt cessation should be avoided. Regulatory information indicates that the dose is typically gradually reduced under the supervision of a healthcare provider.


Q: Does Sertralin Bluefish cause fatigue?

Yes, regulatory safety information lists fatigue (tiredness or exhaustion) as a Very Common officially documented adverse reaction. This means it is among the most frequently reported side effects in patients taking the medication.


Q: Are there any known issues with taking Sertralin Bluefish and alcohol?

Caution is advised regarding the use of alcohol while taking sertraline. This is due to the potential for enhanced central nervous system (CNS) effects that can worsen impairment or increase sedation, though the official labeling does not include a formal prohibition.


Q: Why does Sertralin Bluefish require a prescription?

Sertralin Bluefish is designated as a prescription-only medicine (Rx) because it is a psychoactive compound that works by modulating the central nervous system (CNS). Due to its mechanism of action and the potential for serious side effects and drug interactions, it requires professional medical supervision for diagnosis, correct use, and monitoring.


Q: Can Sertralin Bluefish cause tremors or shaking?

Yes, tremor is listed in the official safety profile as a Common side effect. This means it is an adverse reaction that occurs relatively frequently, reported in less than 1 out of 10 patients.


Q: How quickly does Sertralin Bluefish start working?

Clinical studies for Major Depressive Disorder (MDD) typically assess symptom changes over 6 to 12 weeks. Some research reports indicate that changes in anxiety outcomes have been observed earlier than other core symptoms in certain populations.


Q: What is the difference between Sertralin Bluefish and fluoxetine?

Both medicines belong to the same drug class, Selective Serotonin Re-uptake Inhibitors (SSRIs). Official information notes that sertraline is a mild inhibitor of the CYP2D6 enzyme in the liver. The mild inhibition of the CYP2D6 enzyme by sertraline is a documented difference in the metabolism of these two medications.


Q: Why do doctors prescribe Sertralin Bluefish for anxiety?

Sertraline is formally approved for the treatment of several anxiety-related conditions. This includes Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder (SAD), based on regulatory evaluation of clinical efficacy.


Q: Will Sertralin Bluefish change my personality?

The official labeling does not use the term 'personality change.' However, the label advises monitoring closely for new or sudden changes in mood, behavior, actions, thoughts, or feelings, such as agitation or irritability, especially when starting treatment or changing the dose.


Q: What are the signs that Sertralin Bluefish is starting to work?

Clinical studies for Major Depressive Disorder (MDD) have noted patterns where changes in anxiety outcomes were observed earlier than changes related to core depressive symptoms, such as persistent low mood.


Q: Can Sertralin Bluefish be taken in the evening instead of the morning?

Official guidelines state that the medication should be taken once daily. The tablet formulation may be administered with or without food. Taking it at a consistent time each day is the main requirement.


Q: What kind of research has been done on Sertralin Bluefish?

The evidence base includes various study types, such as Randomized Controlled Trials (RCTs) and long-term continuation studies. These studies have investigated the medication for approved indications like MDD, OCD, Panic Disorder, PTSD, and SAD in both adult and pediatric populations.


Q: How does the Bluefish brand compare to other generic sertraline?

Sertralin Bluefish is a generic presentation of sertraline hydrochloride. All generic products approved by regulatory agencies are required to meet the same strict standards for efficacy and safety as the original product, ensuring consistent quality across brands.


Q: What are the differences between an SSRI like Sertralin Bluefish and a tricyclic antidepressant?

Sertraline is a Selective Serotonin Re-uptake Inhibitor (SSRI), meaning it primarily targets the serotonin system. The official profile notes that sertraline has no significant affinity for the adrenergic or cholinergic receptors, which are often involved with older classes of antidepressants, such as tricyclic antidepressants.


Q: Do I need regular blood tests while on Sertralin Bluefish?

The official labeling notes specific monitoring requirements for certain populations. Caution is advised for conditions like Hyponatraemia (low sodium levels in the blood), and monitoring may be necessary, particularly in older adults. For children and adolescents, monitoring of height and weight is also noted.


Q: Can men and women expect different side effects from Sertralin Bluefish?

The official safety profile lists sexual dysfunction as a Common effect. Certain documented issues, such as ejaculation failure, are specific to males, demonstrating some differences in reported adverse reactions based on sex.


Q: Does Sertralin Bluefish affect the heart?

While the drug's primary action is on the brain, regulatory reports for overdose include adverse events such as tachycardia (rapid heartbeat) and QT-interval prolongation. This indicates a potential for cardiac effects that are documented in the official safety materials.


Q: What are common user experiences after being on Sertralin Bluefish for several months?

Regulatory research includes long-term continuation study designs that have monitored symptom changes and relapse patterns over extended intervals, sometimes up to 80 weeks for specific conditions like Obsessive-Compulsive Disorder (OCD).


Q: Does Sertralin Bluefish have an effect on creativity or emotions?

The general purpose of the medicine is to help stabilize mood and regulate emotional response by restoring chemical balance in the brain. The official label notes documented side effects like anxiety and agitation.


Q: Can exposure to the sun be an issue while taking Sertralin Bluefish?

Some official drug guides suggest that sertraline may cause photosensitivity, which is an increased sensitivity to sunlight. Due to the potential for photosensitivity, official drug guides suggest limiting unnecessary sun exposure and using protective measures such as sunscreen and clothing.


Q: What is the half-life of Sertralin Bluefish?

According to official pharmacokinetics data, the average terminal elimination half-life of sertraline in plasma is approximately 26 hours. This is the time it takes for the concentration of the drug in the body to be reduced by half.


Q: Is Sertralin Bluefish a non-addictive medication?

Sertraline is not classified by regulatory agencies as a controlled substance. However, abruptly stopping the medicine must be avoided as it can cause a documented discontinuation syndrome.


Q: What happens when you combine Sertralin Bluefish with MAO inhibitors?

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated (prohibited). This is due to the high risk of a serious reaction called Serotonin Syndrome, which can involve significant changes in mental status, muscle rigidity, and fever.

Advertisements

How should Sertralin Bluefish be stored and disposed of?

Sertralin Bluefish tablets must be stored according to official regulatory requirements to ensure product stability and safety. The medicine must be kept out of the sight and reach of children.

Storage

The product must be stored at controlled room temperature, generally between 20 C and 25 C (68 F and 77 F). It must be protected from excess heat and moisture; therefore, storage in the bathroom is prohibited. The tablets must remain in the original container with the cap kept tightly closed.

Disposal

Disposal of unused or expired tablets should use a drug take-back program or mail-back service where available. If no take-back option is accessible, the medicine must be removed from its container, mixed with an undesirable substance (like coffee grounds or dirt), sealed in a bag, and then placed in the household trash. Personal information must be scratched out from the label before discarding the original container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sertralin Bluefish found in:

A-Z Index: